“Glucose-Responsive Nanoparticles for Targeted Insulin Delivery in the Treatment of Diabetes”, JOC, vol. 24, no. 4s, pp. 914–927, Sep. 2025, doi: 10.64149/J.Carcinog.24.4s.914-927.